Differential regulation of bladder cancer growth by various glucocorticoids: corticosterone and prednisone inhibit cell invasion without promoting cell proliferation or reducing cisplatin cytotoxicity

被引：0
|
作者：
Hitoshi Ishiguro
Takashi Kawahara
Yichun Zheng
Eiji Kashiwagi
Yi Li
Hiroshi Miyamoto
机构：
[1] Johns Hopkins University School of Medicine,Departments of Pathology and Urology
[2] University of Rochester Medical Center,Department of Pathology and Laboratory Medicine
[3] Zhejiang University School of Medicine,Department of Urology, 2nd Affiliated Hospital
[4] The Johns Hopkins Hospital,The James Buchanan Brady Urological Institute
来源：
Cancer Chemotherapy and Pharmacology | 2014年 / 74卷
关键词：
Bladder cancer; Chemotherapy; Cisplatin; Comedication; Glucocorticoids;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：249 / 255
页数：6
相关论文
共 40 条
  • [1] Differential regulation of bladder cancer growth by various glucocorticoids: corticosterone and prednisone inhibit cell invasion without promoting cell proliferation or reducing cisplatin cytotoxicity
    Ishiguro, Hitoshi
    Kawahara, Takashi
    Zheng, Yichun
    Kashiwagi, Eiji
    Li, Yi
    Miyamoto, Hiroshi
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2014, 74 (02) : 249 - 255
  • [2] The mechanism by which cisplatin, mitomycin, and doxorubicin inhibit cell growth in bladder cancer
    Xie, Qinjian
    Zhang, Shede
    Zhao, Longhe
    Zhang, Tianfeng
    Zhao, Jun
    Wang, Xiaohong
    Ma, Taoye
    Sun, Aoqi
    Ye, Lijuan
    Li, Guorong
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2022, 15 (07): : 208 - 214
  • [3] PARP inhibitors chemopotentiate and synergize with cisplatin to inhibit bladder cancer cell survival and tumor growth
    Bhattacharjee, Sayani
    Sullivan, Matthew J.
    Wynn, Rebecca R.
    Demagall, Alex
    Hendrix, Andrew S.
    Sindhwani, Puneet
    Petros, Firas G.
    Nadiminty, Nagalakshmi
    BMC CANCER, 2022, 22 (01)
  • [4] PARP inhibitors chemopotentiate and synergize with cisplatin to inhibit bladder cancer cell survival and tumor growth
    Sayani Bhattacharjee
    Matthew J. Sullivan
    Rebecca R. Wynn
    Alex Demagall
    Andrew S. Hendrix
    Puneet Sindhwani
    Firas G. Petros
    Nagalakshmi Nadiminty
    BMC Cancer, 22
  • [5] Vascular endothelial growth factor promotes proliferation and invasion in bladder cancer cell lines
    Nakanishi, Ryoichi
    Kusuhara, Yoshihiro
    Taue, Ryuichl
    Yamaguchi, Kunihisa
    Nakatsuji, Hiroyoshi
    Kishimoto, Tomoteru
    Oka, Natsuo
    Isaki, Hirofumi
    Takahashi, Masayuki
    Fukumori, Tomoharu
    Nishitani, Masa-aki
    Kanayama, Hiro-omi
    CLINICAL & EXPERIMENTAL METASTASIS, 2007, 24 (04) : 256 - 256
  • [6] RAB38 promotes bladder cancer growth by promoting cell proliferation and motility
    Tian, Da-Wei
    Liu, Sheng-Lai
    Jiang, Li-Ming
    Wu, Zhou-Liang
    Gao, Jie
    Hu, Hai-Long
    Wu, Chang-Li
    WORLD JOURNAL OF UROLOGY, 2019, 37 (09) : 1889 - 1897
  • [7] RAB38 promotes bladder cancer growth by promoting cell proliferation and motility
    Da-Wei Tian
    Sheng-Lai Liu
    Li-Ming Jiang
    Zhou-Liang Wu
    Jie Gao
    Hai-Long Hu
    Chang-Li Wu
    World Journal of Urology, 2019, 37 : 1889 - 1897
  • [8] Xiaoaiping combined with cisplatin can inhibit proliferation and invasion and induce cell cycle arrest and apoptosis in human ovarian cancer cell lines
    Zheng, Ai-Wen
    Chen, Ya-Qing
    Fang, Jing
    Zhang, Ying-Li
    Jia, Dong-Dong
    BIOMEDICINE & PHARMACOTHERAPY, 2017, 89 : 1172 - 1177
  • [9] Thiosemicarbazone-based selective proliferation inactivators inhibit gastric cancer cell growth, invasion, and migration
    Hu, Biao
    Wang, Bo
    Zhao, Bing
    Guo, Qian
    Li, Zhong-Hua
    Zhang, Xin-Hui
    Liu, Guang-Yao
    Liu, Ying
    Tang, Ying
    Luo, Fan
    Du, Ya
    Chen, Ya-Xin
    Ma, Li-Ying
    Liu, Hong-Min
    MEDCHEMCOMM, 2017, 8 (12) : 2173 - 2180
  • [10] Contrary Regulation of Bladder Cancer Cell Proliferation and Invasion by Dexamethasone-Mediated Glucocorticoid Receptor Signals
    Zheng, Yichun
    Izumi, Koji
    Li, Yi
    Ishiguro, Hitoshi
    Miyamoto, Hiroshi
    MOLECULAR CANCER THERAPEUTICS, 2012, 11 (12) : 2621 - 2632
1234